ATYR PHARMA INC (ATYR) Stock Earnings & Estimates
USA - NASDAQ:ATYR - US0021202025 - Common Stock
0.7214 USD
-0.07 (-9.28%)
0.725 USD
+0 (+0.5%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.386M | 353K -96.60% | 235K -33.43% | 1.224M 420.85% | 24.718M 1,919.44% | 127.68M 416.55% | 291.08M 127.98% | 550.43M 89.10% | 805M 46.25% | 733.83M -8.84% | 881.83M 20.17% | |
| EBITDA YoY % growth | -46.172M -37.66% | -54.327M -17.66% | -66.374M -22.17% | -72.777M -9.65% | -72.369M 0.56% | -65.892M 8.95% | 74.256M 212.69% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -46.404M -36.42% | -54.919M -18.35% | -67.914M -23.66% | -76.192M -12.19% | -82.819M -8.70% | -32.126M 61.21% | 141.62M 540.83% | 360.89M 154.83% | 580.19M 60.77% | 533.83M -7.99% | 662.22M 24.05% | |
| Operating Margin | -446.79% | -15,557.79% | -28,899.57% | -6,224.82% | -335.05% | -25.16% | 48.65% | 65.57% | 72.07% | 72.75% | 75.10% | |
| EPS YoY % growth | -1.60 14.89% | -0.96 40.00% | -0.87 9.37% | -0.75 13.59% | -0.66 12.62% | -0.10 84.99% | 1.17 1,288.27% | 2.90 147.09% | 4.36 50.50% | 4.19 -3.86% | 5.06 20.78% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 23.28% | -0.18 0.52% | -0.19 -10.00% | -0.21 4.18% | -0.13 24.86% | -0.14 23.10% |
| Revenue Q2Q % growth | 1.53M | 14.331M 836.67% | 16.718M | |||
| EBITDA Q2Q % growth | -17.952M -8.13% | -18.156M -27.14% | -15.81M -2.73% | -16.218M 17.01% | N/A | N/A |
| EBIT Q2Q % growth | -17.965M 0.98% | -19.813M -25.24% | -17.844M -13.13% | -18.586M 8.50% | -16.4M 8.72% | -9.578M 51.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.22 4.35% | -0.19 | -0.03 | -16.94% |
| Q1 2025 Q2Q % growth | -0.17 26.09% | -0.19 | 0.02 | 12.28% |
| Q4 2024 Q2Q % growth | -0.18 28.00% | -0.23 | 0.05 | 21.92% |
| Q3 2024 Q2Q % growth | -0.23 -15.00% | -0.22 | -0.01 | -2.50% |
| Q2 2024 Q2Q % growth | -0.23 -4.55% | -0.24 | 0.01 | 5.26% |
| Q1 2024 Q2Q % growth | -0.23 20.69% | -0.24 | 0.01 | 4.45% |
| Q4 2023 Q2Q % growth | -0.25 3.85% | -0.24 | -0.01 | -2.98% |
| Q3 2023 Q2Q % growth | -0.20 56.52% | -0.23 | 0.03 | 13.24% |
| Q2 2023 Q2Q % growth | -0.22 50.00% | -0.28 | 0.06 | 22.57% |
| Q1 2023 Q2Q % growth | -0.29 34.09% | -0.41 | 0.12 | 28.62% |
| Q4 2022 Q2Q % growth | -0.26 16.13% | -0.49 | 0.23 | 46.90% |
| Q3 2022 Q2Q % growth | -0.46 -9.52% | -0.47 | 0.01 | 2.32% |
| Q2 2022 Q2Q % growth | -0.44 31.25% | -0.39 | -0.05 | -12.92% |
| Q1 2022 Q2Q % growth | -0.44 13.73% | -0.34 | -0.10 | -30.06% |
| Q4 2021 Q2Q % growth | -0.31 34.04% | -0.29 | -0.02 | -7.27% |
| Q3 2021 Q2Q % growth | -0.42 38.24% | -0.61 | 0.19 | 30.88% |
| Q2 2021 Q2Q % growth | -0.64 7.25% | -0.52 | -0.12 | -23.51% |
| Q1 2021 Q2Q % growth | -0.51 -304.00% | -0.32 | -0.19 | -57.48% |
| Q4 2020 Q2Q % growth | -0.47 69.48% | -0.84 | 0.37 | 44.03% |
| Q3 2020 Q2Q % growth | -0.68 53.74% | -0.76 | 0.08 | 10.31% |
| Q2 2020 Q2Q % growth | -0.69 61.67% | -0.74 | 0.05 | 7.33% |
| Q1 2020 Q2Q % growth | 0.25 109.92% | -0.18 | 0.43 | 236.17% |
| Q4 2019 Q2Q % growth | -1.54 | -1.62 | 0.08 | 5.04% |
| Q3 2019 Q2Q % growth | -1.47 | -1.76 | 0.29 | 16.53% |
| Q2 2019 Q2Q % growth | -1.80 | -2.80 | 1.00 | 35.69% |
| Q1 2019 Q2Q % growth | -2.52 | -3.23 | 0.71 | 21.92% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q4 2024 Q2Q % growth | 11.332K | -11.332K | -100.00% | |
| Q3 2024 Q2Q % growth | -100.00% | 17.003K | -17.003K | -100.00% |
| Q2 2024 Q2Q % growth | 24.48K | -24.48K | -100.00% | |
| Q1 2024 Q2Q % growth | 235K | 20.4K | 214.6K | 1,051.96% |
| Q4 2023 Q2Q % growth | -100.00% | 53.04K | -53.04K | -100.00% |
| Q3 2023 Q2Q % growth | 353K | 1.53M | -1.177M | -76.93% |
| Q2 2023 Q2Q % growth | 534.776K | -534.776K | -100.00% | |
| Q1 2023 Q2Q % growth | 309.397K | -309.397K | -100.00% | |
| Q4 2022 Q2Q % growth | 10.386M | 218.576K | 10.167M | 4,651.67% |
| Q3 2022 Q2Q % growth | 339.997K | -339.997K | -100.00% | |
| Q2 2022 Q2Q % growth | 2.04M | -2.04M | -100.00% | |
| Q1 2022 Q2Q % growth | 170.003K | -170.003K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | 3.08M | -3.08M | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 233.141K | -233.141K | -100.00% |
| Q2 2021 Q2Q % growth | -100.00% | 634.236K | -634.236K | -100.00% |
| Q1 2021 Q2Q % growth | -100.00% | 4.064M | -4.064M | -100.00% |
| Q4 2020 Q2Q % growth | 2.053M 1,325.69% | 128.52K | 1.924M | 1,497.42% |
| Q3 2020 Q2Q % growth | 148K -19.57% | 105.397K | 42.603K | 40.42% |
| Q2 2020 Q2Q % growth | 189K 101.06% | 406.98K | -217.98K | -53.56% |
| Q1 2020 Q2Q % growth | 8.065M | 4.487M | 3.578M | 79.74% |
| Q4 2019 Q2Q % growth | 144K | 158.783K | -14.783K | -9.31% |
| Q3 2019 Q2Q % growth | 184K | 61.2K | 122.8K | 200.65% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -16.3% | -2.68% | -13% |
| Revenue | 0% | -12.52% | -10% | -50.9% |